Search for persons
X
?
1
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 fo..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t007. , 2024
doi:10.1371/journal.pone.0297092.t007. , 2024
?
2
Most commonly reported side effects in participants receivi..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t003. , 2024
doi:10.1371/journal.pone.0297092.t003. , 2024
?
3
Driving patterns of participants on prescribed THC vs presc..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t006. , 2024
doi:10.1371/journal.pone.0297092.t006. , 2024
?
4
Characteristics of prescribed medicinal cannabis users by c..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t001. , 2024
doi:10.1371/journal.pone.0297092.t001. , 2024
?
5
Reported improvement in main condition: comparing prescribe..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t004. , 2024
doi:10.1371/journal.pone.0297092.t004. , 2024
?
6
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 fo..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t007. , 2024
doi:10.1371/journal.pone.0297092.t007. , 2024
?
7
Reported improvement in main condition: comparing prescribe..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t004. , 2024
doi:10.1371/journal.pone.0297092.t004. , 2024
?
8
Main reasons for use of prescribed medicinal cannabis users..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t002. , 2024
doi:10.1371/journal.pone.0297092.t002. , 2024
?
9
Other medication used versus prescribed cannabinoids:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t005. , 2024
doi:10.1371/journal.pone.0297092.t005. , 2024
?
10
Characteristics of prescribed medicinal cannabis users by c..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t001. , 2024
doi:10.1371/journal.pone.0297092.t001. , 2024
?
11
Most commonly reported side effects in participants receivi..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t003. , 2024
doi:10.1371/journal.pone.0297092.t003. , 2024
?
12
Other medication used versus prescribed cannabinoids:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t005. , 2024
doi:10.1371/journal.pone.0297092.t005. , 2024
?
13
Driving patterns of participants on prescribed THC vs presc..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t006. , 2024
doi:10.1371/journal.pone.0297092.t006. , 2024
?
14
Main reasons for use of prescribed medicinal cannabis users..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t002. , 2024
doi:10.1371/journal.pone.0297092.t002. , 2024
?
15
Driving-related behaviors, attitudes, and perceptions among..:
Arkell, Thomas R ; Abelev, Sarah V ; Mills, Llewellyn...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481606/. , 2023
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481606/. , 2023